Last update 21 Nov 2024

64Cu-LNTH-1363S

Overview

Basic Info

Drug Type
Diagnostic radiopharmaceuticals
Synonyms
Target
FAP
Action-
Mechanism
FAP antagonists(Fibroblast activation protein alpha antagonists), PET imaging(Positron-emission tomography enhancers)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication
Colorectal CancerEsophageal CarcinomaPancreatic Cancer+ [2]
Inactive Indication-
Originator Organization
Lantheus Medical Imaging, Inc.
Active Organization
Lantheus Medical Imaging, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with 64Cu-LNTH-1363S
NCT06298916
/ RecruitingPhase 1/2
A Phase 1/2a Study Utilizing 64Cu-LNTH-1363S (64Cu Radiolabeled FAPi PET/CT Imaging Agent) in Patients with Sarcoma or Gastrointestinal Tract Cancer (PHANTOM Trial)
100 Clinical Results associated with 64Cu-LNTH-1363S
Login to view more data
100 Translational Medicine associated with 64Cu-LNTH-1363S
Login to view more data
100 Patents (Medical) associated with 64Cu-LNTH-1363S
Login to view more data
100 Deals associated with 64Cu-LNTH-1363S
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colorectal CancerPhase 2
United States
Lantheus Medical Imaging, Inc.
01 Nov 2024
Esophageal CarcinomaPhase 2
United States
Lantheus Medical Imaging, Inc.
01 Nov 2024
Pancreatic CancerPhase 2
United States
Lantheus Medical Imaging, Inc.
01 Nov 2024
SarcomaPhase 2
United States
Lantheus Medical Imaging, Inc.
01 Nov 2024
Stomach CancerPhase 2
United States
Lantheus Medical Imaging, Inc.
01 Nov 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free